160 related articles for article (PubMed ID: 11728688)
1. Phase I study of twice-weekly gemcitabine and concurrent thoracic radiation for patients with locally advanced non-small-cell lung cancer.
Blackstock AW; Lesser GJ; Fletcher-Steede J; Case LD; Tucker RW; Russo SM; White DR; Miller A
Int J Radiat Oncol Biol Phys; 2001 Dec; 51(5):1281-9. PubMed ID: 11728688
[TBL] [Abstract][Full Text] [Related]
2. Sequential (gemcitabine/vinorelbine) and concurrent (gemcitabine) radiochemotherapy with FDG-PET-based target volume definition in locally advanced non-small cell lung cancer: first results of a phase I/II study.
Gagel B; Piroth M; Pinkawa M; Reinartz P; Krohn T; Kaiser HJ; Stanzel S; Breuer C; Asadpour B; Schmachtenberg A; Eble MJ
BMC Cancer; 2007 Jun; 7():112. PubMed ID: 17598906
[TBL] [Abstract][Full Text] [Related]
3. Phase Ia/Ib chemo-radiation trial of gemcitabine and dose-escalated thoracic radiation in patients with stage III A/B non-small cell lung cancer.
Blackstock AW; Ho C; Butler J; Fletcher-Steede J; Case LD; Hinson W; Miller AA
J Thorac Oncol; 2006 Jun; 1(5):434-40. PubMed ID: 17409896
[TBL] [Abstract][Full Text] [Related]
4. Gemcitabine, cisplatin, and hyperfractionated accelerated radiotherapy for locally advanced non-small cell lung cancer.
Zwitter M; Kovac V; Smrdel U; Strojan P
J Thorac Oncol; 2006 Sep; 1(7):662-6. PubMed ID: 17409933
[TBL] [Abstract][Full Text] [Related]
5. A phase I/II trial of induction chemotherapy with carboplatin and gemcitabine followed by concurrent vinorelbine and paclitaxel with chest radiation in patients with stage III non-small cell lung cancer.
Argiris A; Liptay M; LaCombe M; Marymont M; Kies MS; Sundaresan S; Masters G
Lung Cancer; 2004 Aug; 45(2):243-53. PubMed ID: 15246197
[TBL] [Abstract][Full Text] [Related]
6. A Phase I study of gemcitabine with concurrent radiotherapy in stage III, locally advanced non-small cell lung cancer.
van Putten JW; Price A; van der Leest AH; Gregor A; Little FA; Groen HJ
Clin Cancer Res; 2003 Jul; 9(7):2472-7. PubMed ID: 12855620
[TBL] [Abstract][Full Text] [Related]
7. Concurrent infusional gemcitabine and radiation in the treatment of advanced unresectable GI malignancy: a phase I study.
Mohiuddin M; Kudrimoti M; Regine WF; McGrath PC; Hanna N; John W
Cancer J; 2002; 8(3):255-62. PubMed ID: 12074325
[TBL] [Abstract][Full Text] [Related]
8. Phase I/IIa study of cisplatin and gemcitabine as induction chemotherapy followed by concurrent chemoradiotherapy with gemcitabine and paclitaxel for locally advanced non-small-cell lung cancer.
Divers SG; Spencer SA; Carey D; Busby EM; Hyatt MD; Robert F
J Clin Oncol; 2005 Sep; 23(27):6664-73. PubMed ID: 16170174
[TBL] [Abstract][Full Text] [Related]
9. Phase II study of low-dose paclitaxel with timed thoracic radiotherapy followed by adjuvant gemcitabine and carboplatin in unresectable stage III non-small cell lung cancer.
Zhang J; Gay HA; Russo S; Parent T; Aljumaily R; Walker PR
Lung Cancer; 2014 Jan; 83(1):67-72. PubMed ID: 24246506
[TBL] [Abstract][Full Text] [Related]
10. Phase I trial of outpatient weekly paclitaxel and concurrent radiation therapy for advanced non-small-cell lung cancer.
Choy H; Akerley W; Safran H; Clark J; Rege V; Papa A; Glantz M; Puthawala Y; Soderberg C; Leone L
J Clin Oncol; 1994 Dec; 12(12):2682-6. PubMed ID: 7989944
[TBL] [Abstract][Full Text] [Related]
11. Phase I trial of twice-weekly gemcitabine and concurrent radiation in patients with advanced pancreatic cancer.
Blackstock AW; Bernard SA; Richards F; Eagle KS; Case LD; Poole ME; Savage PD; Tepper JE
J Clin Oncol; 1999 Jul; 17(7):2208-12. PubMed ID: 10561277
[TBL] [Abstract][Full Text] [Related]
12. High incidence of pulmonary toxicity of weekly docetaxel and gemcitabine in patients with non-small cell lung cancer: results of a dose-finding study.
Kouroussis C; Mavroudis D; Kakolyris S; Voloudaki A; Kalbakis K; Souglakos J; Agelaki S; Malas K; Bozionelou V; Georgoulias V
Lung Cancer; 2004 Jun; 44(3):363-8. PubMed ID: 15140550
[TBL] [Abstract][Full Text] [Related]
13. Induction chemotherapy with cisplatin and gemcitabine followed by concurrent chemoradiation with twice-weekly gemcitabine in unresectable stage III non-small cell lung cancer: final results of a phase II study.
Blanco R; Solé J; Montesinos J; Mesía C; Algara M; Terrassa J; Gay M; Domenech M; Bastus R; Bover I; Nogué M; Vadell C;
Lung Cancer; 2008 Oct; 62(1):62-71. PubMed ID: 18440089
[TBL] [Abstract][Full Text] [Related]
14. Combined-modality therapy for advanced non-small cell lung cancer: paclitaxel and thoracic irradiation.
Choy H; Yee L; Cole BF
Semin Oncol; 1995 Dec; 22(6 Suppl 15):38-44. PubMed ID: 8643969
[TBL] [Abstract][Full Text] [Related]
15. Phase I study of radical thoracic radiation, weekly irinotecan, and cisplatin in locally advanced non-small cell lung carcinoma.
Langer CJ; Somer R; Litwin S; Feigenberg S; Movsas B; Maiale C; Sherman E; Millenson M; Nicoloau N; Huang C; Treat J
J Thorac Oncol; 2007 Mar; 2(3):203-9. PubMed ID: 17410043
[TBL] [Abstract][Full Text] [Related]
16. Phase I trial of gemcitabine and cisplatin in advanced non-small cell lung cancer: a preliminary report.
Shepherd FA; Burkes R; Cormier Y; Crump M; Feld R; Strack T
Lung Cancer; 1996 Feb; 14(1):135-44. PubMed ID: 8696717
[TBL] [Abstract][Full Text] [Related]
17. Phase I trial of weekly gemcitabine and concurrent radiotherapy in patients with inoperable non-small-cell lung cancer.
Trodella L; Granone P; Valente S; Turriziani A; Macis G; Corbo GM; Margaritora S; Cesario A; D'Angelillo RM; Gualano G; Ramella S; Galetta D; Cellini N
J Clin Oncol; 2002 Feb; 20(3):804-10. PubMed ID: 11821464
[TBL] [Abstract][Full Text] [Related]
18. A dose-escalation study of irinotecan (CPT-11) in combination with gemcitabine in patients with advanced non-small cell lung cancer previously treated with a cisplatin-based front line chemotherapy.
Kakolyris SS; Kouroussis C; Koukourakis M; Kalbakis K; Mavroudis D; Vardakis N; Georgoulias V
Anticancer Res; 2002; 22(3):1891-6. PubMed ID: 12168889
[TBL] [Abstract][Full Text] [Related]
19. Combined therapy with topotecan and gemcitabine in patients with inoperable or metastatic non-small cell lung cancer.
Dabrow MB; Francesco MR; Gilman PB; Cantor R; Rose L; Meyer TJ
Cancer Invest; 2003; 21(4):517-25. PubMed ID: 14533441
[TBL] [Abstract][Full Text] [Related]
20. A phase I study of gemcitabine plus palliative radiation therapy for advanced lung cancer.
Choi B; Robins HI; Schiller J; Mehta M
Cancer Chemother Pharmacol; 2008 Dec; 63(1):175-9. PubMed ID: 18305938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]